Terms ending in 2029
Every in-force patent on GlaxoSmithKline LLC's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,816,395 | Pyrrolidinone Anilines as Progesterone Receptor Modulators In force · Medium confidence | GlaxoSmithKline LLC | In force | Medium confidence | |
| US 9,107,856 | Dental Appliance Cleanser In force · High confidence | Block Drug Company Inc. | In force | High confidence | |
| US 8,940,772 | Nicotine Lozenge Composition In force · Low confidence | Haleon US Holdings LLC | In force | Low confidence | |
| US 8,642,759 | Benzene Sulfonamide Thiazole and Oxazole Compounds In force · Medium confidence | Novartis AG | In force | Medium confidence | |
| US 9,233,956 | Benzene Sulfonamide Thiazole and Oxazole Compounds In force · Low confidence | Novartis Pharmaceuticals Corporation | In force | Low confidence | |
| US 11,325,972 | Methods of Treatment of Eosinophilic Bronchitis with an ANTI-IL-5 Antibody In force · Low confidence | GlaxoSmithKline LLC | In force | Low confidence | |
| US D733,552 | Package In force · High confidence | Haleon US Holdings LLC | In force | High confidence | |
| US 8,183,372 | Substituted 9,11-Dioxo-2,3,4a,5,9,11,13,13a-octahydor-1H-pyrido[1,2-a]pyrrolo[1',2':3,4]imidazo[1,2-d]pyrazines In force · High confidence | Viiv Healthcare Company | In force | High confidence | |
| US 8,217,034 | Chemical Compounds In force · High confidence | Viiv Healthcare Company | In force | High confidence | |
| US 8,093,242 | Crystalline Forms of a Pyridine Derivative In force · High confidence | Kandy Therapeutics Limited | In force | High confidence | |
| 8 more term ends in 2029 · Pro | |||||
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
6 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.